• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Trendwatch: The State of Femtech in 2022, A VC Fund Focused on Telehealth & Investment Round-up January ’22

By Femtech Insider News, Trend Watch January 31, 2022
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

News, Trend Watch November 22, 2022
Spotlight: Pediatric Innovation
Access, Health Equity, Menstrual Health, News, Reports October 19, 2023
INTIMINA Highlights Period Poverty on College Campuses: 20% of Students Face Difficult Choices Over Menstrual Product Costs
Recent Posts
  • FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
  • Why Investors Are Betting Big on Incontinence
  • Australian Medtech NinaMED Launches with $13.75M to Develop Non-Invasive Wearable for Overactive Bladder
  • Inside SPRIND’s Push to Build a Continuous Hormone Monitoring Industry in Europe
  • BlueWind Medical Raises $47.8M to Commercialize Implantable Neuromodulation Device for Urgency Urinary Incontinence

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.